近期论文
查看导师最新文章
(温馨提示:请注意重名现象,建议点开原文通过作者单位确认)
发表论文(#为共同第一,*为通讯作者)
[1].ZhongS,HanW,HouC,LiuJ,WuL,LiuM,LiangZ,LinH,ZhouL,LiuS,TangL*.RelationofTranscriptionalFactorstotheExpressionandActivityofCytochromeP450andUDP-Glucuronosyltransferases1AinHumanLiver:Co-ExpressionNetworkAnalysis.AAPSJ,2017Jan;19(1):203-214.
[2].LiuJ,YuX,ZhongS,HanW,LiangZ,YeL,ZhaoJ,LiuM,LiuS,WeiQ,TangL*.HepaticandRenalMetabolismofGenistein:anIndividual-basedModeltoPredictGlucuronidationBehaviorofGenisteininDifferentOrgans.JournalofPharmaceuticalandBiomedicalAnalysis.2017.doi:10.1016/j.jpba.2017.02.020.
[3].MoH,WuQ,MiaoJ,LuoC,HongX,WangY,TangL,HouFF,LiuY,ZhouL.ChemokineReceptorCXCR4PlaysaCrucialRoleinMediatingOxidativeStress-InducedPodocyteInjury.AntioxidRedoxSignal.2016Dec13.DOI:10.1089/ars.2016.6758.
[4].LiuJE#,RenB#,TangL#,TangQJ,LiuXY,LiX,BaiX,ZhongWP,MengJX,LinHM,WuH,ChenJY,ZhongSL*.TheindependentcontributionofmiRNAstothemissingheritabilityinCYP3A4/5functionalityandthemetabolismofatorvastatin.ScientificReports.2016May23;6:26544.doi:10.1038/srep26544.
[5].ZhongWP,WuH3ChenJY,LiXX,LinHM,ZhangB,ZhangZW,MaDL,SunS,LiHP,MaiLP,HeGD,WangXP,LeiHP,ZhouHK,TangL,LiuSW,ZhongSL.Agenome-wideassociationstudyidentifiesnovelgeneticlocithatmodifyantiplateleteffectsandpharmacokineticsofclopidogrel.ClinPharmacolTher.2016Dec16.doi:10.1002/cpt.589.
[6].ChenR,HeJ,TongX,TangL,LiuM*.AReviewonPhytochemistry,Pharmacology,QualityControlandPharmacokinetics.Molecules.2016May30;21(6).pii:E710.
[7].HuY,WangZ,HuangX,XiaB,TangL,ZhengZ,YeL.OxidativemetabolismofkoumineismainlycatalyzedbymicrosomalCYP3A4/3A5.Xenobiotica.2016Aug8:1-8.
[8].TangQJ,LinH,HeG,LiuJ,WuH,LiX,ZhongW,TangL,MengJ,ZhangM,LiH,ChenJ,ZhongS*,WangL*.PlasmamiR-142accountingforthemissingheritabilityofCYP3A4/5functionalityisassociatedwithpharmacokineticsofclopidogrel.Pharmacogenomics.2016.Aug24.
[9].ZhongW,WangX,TangL,MaiL,ChenXP,HeG,ZhengZ,ZhongS*.SimultaneousDeterminationofTicagrelorandItsMetabolitesinHumanPlasmaandUrineUsingLiquidChromatography-TandemMassSpectrometry.JournalofAnalyticalToxicology2016May10.pii:bkw039.
[10].WuL,LiuJ,HanW,ZhouX,YuX,LiuS,TangL*.Time-dependentmetabolismofluteolinbyhumanUDP-glucuronosyltransferases(UGTs)anditsintestinalfirst-passglucuronidationinmice.JournalofAgriculturalandFoodChemistry.2015,63,8722-8733.
[11].WuL,ZhongW,LiuJ,HanW,ZhongS,WeiQ,LiuS,TangL*.HumanmicrosomalcytochromeP450-mediatedreductionofoxysophocarpine,anactiveandhighlytoxicconstituentderivedfromSophoraflavescensspecies,anditsintestinalabsorptionandmetabolisminrat.Fitoterapia.2015Sep;105:26-36.
[12].TangL,LiY,ChenW,ZengS,DongL,PengX,JiangW,HuM,LiuZ*.Breastcancerresistanceprotein-mediatedeffluxofluteolinglucuronidesinHeLacellsoverexpressingUDP-glucuronosyltransferase1A9.PharmaceuticalResearch.2014,31,847-860.
[13].TangL,DongL,PengX,ShiJ,ZhouF,LiuZ*.PharmacokineticcharacterizationofoxymatrineandmatrineinratsafteroraladministrationofradixSophoraetonkinensisextractandoxymatrinebysensitiveandrobustUPLC-MS/MSmethod.JournalofPharmaceuticalandBiomedicalAnalysis,2013,83,179–185.
[14].FanY#,TangL#,ZhouJ,FengQ,XiaB,LiuZ*.SimultaneousdeterminationofsulfationandglucuronidationofflavonesinFVB/Nmouseintestineinvitroandinvivo.JournalofAppliedToxicology,2013,33(4),273-280.
[15].YeL,LuL,LiY,ZengS,YangX,ChenW,FengQ,LiuW,TangL,LiuZ*,PotentialroleofATP-bindingcassettetransportersintheintestinaltransportofrhein.FoodChemistryToxicology.2013,58:p.301-305.
[16].TangL#,FengQ#,ZhaoJ,DongL,LiuW,YangC,LiuZ*.InvolvementofUDP-glucuronosyltranferasesandsulfotransferasesintheliverandintestinalfirst-passmetabolismofsevenflavonesinC57miceandhumans.FoodandChemicalToxicology,2012,50(5):1460-7.
[17].TangL,YangC,ZhouJ,XiaB,HuM,LiuZ*.Systematicstudiesofsulfationandglucuronidationof12flavonoidsinthemouseliverS9fractionrevealsbothuniqueandsharedpositionalpreferences.JournalofAgriculturalandFoodChemistry.2012,28;60(12):3223-33.
[18].ZhuL,YangX,ZhouJ,TangL,XiaB,HuM,ZhouFY,LiuZ*.TheexposureofhighlytoxicaconitinedoesnotsignificantlyimpacttheactivityandexpressionofcytochromeP4503Ainratsdeterminedbyanovelultra-performanceliquidchromatography-tandemmassspectrometricmethodofaspecificprobebuspirone.FoodandChemicalToxicology.2012Oct22;51:396-403.
[19].ZhaoJ,SuC,YangCP,TangL,SuWW,LiuZQ*.DeterminationofginsenosidesRb1,Rb2,andRb3inratplasmabyarapidandsensitiveliquidchromatographytandemmassspectrometrymethod:Applicationinapharmacokineticstudy.JournalofPharmaceuticalandBiomedicalAnalysis.2012;64-65:94-7.
[20].ZhengZJ,YanTM,ChenWY,YeL,TangL,LiuZQ*,PharmacokineticdeterminationofephedrineinHerbaEphedraeandWuTouTangdecoctionsinratsusingultraperformanceliquidchromatographytandemmassspectrometry.Xenobiotica.2012,42(8):775-83.
[21].TangL,GongY,LvC,YeL,LiuL,LiuZ*.PharmacokineticsofaconitineasthetargetedmarkerofFuzi(Aconitumcarmichaeli)followingsingleandmultipleoraladministrationsofFuziextractsinratbyUPLC/MS/MS.JournalofEthnopharmacology,2012Jun1;141(2):736-41.
[22].TangL,YeL,LvC,ZhengZ,GongY,LiuZ*.InvolvementofCYP3A4/5andCYP2D6inthemetabolismofaconitineusinghumanlivermicrosomesandrecombinantCYP450enzymes.ToxicologyLetters,2011,202,47–54.
[23].SinghR,WuB,TangL,HuM*.Uridinediphosphateglucuronosyltransferaseisoform-dependentregiospecificityofglucuronidationofflavonoids.JournalofAgriculturalandFoodChemistry.2011,59(13),7452-64.
[24].YeL,WangT,TangL,LiuW,ZhenY,ZhouJ,ZhengZ,CaiZ,HuM*,LiuZ*.PoororalbioavaibilityofapromisinganticancergentandrographolideisduetoextensivemetabolismandeffluxbyP-glycoprotein.JournalofPharmaceuticalSciences.2011;100(11):5007-17.
[25].YeL,WangT,YangC,TangL,ZhouJ,LvC,GongY,JiangZ,LiuZ*.MicrosomalcytochromeP450mediatedmetabolismofhypaconitine,anactiveandhighlytoxicconstituentderivedfromAconitumspecies.ToxicologyLetters,2011;204:81-91.
[26].YangC,TangL,LvC,YeL,XiaB,HuM,LiuZ*.Sulfationofselectedmono-hydroxyflavonesbysulfotransferasesinvitro:aspeciesandgendercomparison.Journalofpharmacyandpharmacology.2011,63:967–970.
[27].YeL,TangL,GongY,LvC,ZhengZ,JiangZ,LiuZ*.CharacterizationofmetabolitesandhumanP450isoformsinvolvedinthemicrosomalmetabolismofmesaconitine.Xenobiotica.2011Jan;41(1):46-58.
[28].TangL,YeL,SinghR,WuB.,LvC.,ZhaoJ,LiuZ,HuM.Useofglucuronidationfingerprintingtodescribeandpredictmono-anddihydroxyflavonemetabolismbyrecombinantUGTisoformsandhumanintestinalandlivermicrosomes.MolecularPharmaceutics.2010,7,664-679.
[29].LiuW#,TangL#,YeL,CaiZ,XiaB,ZhangJ,HuM,LiuZ.Speciesandgenderdifferencesaffectthemetabolismofemodinviaglucuronidation.TheAAPSJournal.2010,12,424-436.
[30].SinghR,WuB,TangL,LiuZ,HuM*.Identificationofthepositionofmono-O-glucuronideofflavonesandflavonolsbyanalyzingshiftinonlineUVspectrum(lambdamax)generatedfromanonlinediodearraydetector.JournalofAgriculturalandFoodChemistry.2010,58,9384-9395.
[31].ZhouQ,ZhengZ,XiaB,TangL,LvC,LiuW,LiuZ*,HuM*.Useofisoform-specificUGTmetabolismtodetermineanddescriberatesandprofilesofglucuronidationofwogoninandoroxylinAbyhumanliverandintestinalmicrosomes.PharmaceuticalResearch.2010,27,1568-1583.
[32].YangZ,ZhuW,GaoS,XuH,WuB,KulkarniK,SinghR,TangL,HuM.SimultaneousdeterminationofgenisteinanditsfourphaseIImetabolitesinbloodbyasensitiveandrobustUPLC-MS/MSmethod:Applicationtoanoralbioavailabilitystudyofgenisteininmice.JournalofPharmaceuticalandBiomedicalAnalysis.2010,53,81-89.
[33].WangS,KulkarniK,TangL,WangJ,YinT,DaidojiT,YokotaH,HuM.Dispositionofflavonoidsviaentericrecycling:UDP-glucuronosyltransferase(UGT)1AsdeficiencyinGunnratsiscompensatedbyincreasesinUGT2Bsactivities.JournalofPharmacologyandExperimentalTherapeutics.2009,329,1023-1031.
[34].ZhouX,TangL*,LiuY.AnisomericmixtureofnovelcerebrosidesisolatedfromImpatienspritzelliireduceslipopolysaccharide-inducedreleaseofIL-18fromhumanperipheralbloodmononuclearcells.Lipids.2009,44,759-763.
[35].TangL,SinghR,LiuZ,HuM.StructureandconcentrationchangesaffectcharacterizationofUGTisoform-specificmetabolismofisoflavones.MolecularPharmaceutics.2009,6,1466-1482.